Background
In most developed countries survivors of adult cancers form a large and growing group; there are 2 million cancer survivors in the UK, and this is estimated to double by 2030 [1] . One potentially modifiable predictor of HRQoL is a patient's own personal beliefs about their illness and its treatment, and their emotional responses towards it, which are known as illness representations or perceptions. Illness perceptions are theorised to affect disease adaptation and outcomes within the framework of the common6sense self6regulation model (SRM) of illness [8, 9] . The SRM posits that, when faced with illness, individuals form beliefs about the disease (cognitive representation) and experience an emotional reaction (emotional representation), which together affect physical and psychosocial outcomes, primarily via influencing coping responses. Theory and research suggest illness cognitions are organised around five interrelated dimensions: beliefs about the diagnostic label and symptoms associated with the illness, its aetiology, duration, consequences, and controllability/curability [10, 11] . Quantitative research into illness representations has overwhelmingly used the Revised Illness Perception Questionnaire [12] (or its predecessor or short6form), which assesses these cognitive dimensions as well as a patient's emotional representation.
Over the last 15 years, cross6sectional and longitudinal studies in various diseases, including diabetes, asthma and myocardial infarction, have found illness representations to account for a significant proportion of the variance in a range of illness outcomes, including medication adherence, psychological morbidity and HRQoL, even after controlling for sociodemographic and disease predictors [11, 13] . This suggests that illness representations play an important role in patient outcomes, and that interventions to change these representations could potentially improve patients' wellbeing and outcomes. Although (impact of the illness on their life), personal control (how much influence they have over the illness), treatment control (treatability of the illness ), illness coherence (how well they understand the illness) and timeline-cyclical (whether the illness trajectory is constant or cyclical), as well as emotional representations (emotional impact of the illness). In addition, the IPQ6R also assesses beliefs about identity (symptom attribution) and causes (of the illness), although the causes dimension was omitted from the ePOCS feasibility study as it was felt by patients on the study steering group that it may distress respondents. The core dimensions are assessed by 38 items, such as "my cancer is a serious condition", rated from 1 (strongly disagree) to 5 (strongly agree), and the identity scale is assessed by 14 symptoms (e.g. headaches) rated yes/no according to whether the symptom has been experienced "since my cancer" and is "related to my cancer". Higher scores indicate a stronger illness identity, stronger perceptions of illness chronicity, a cyclical timeframe and negative consequences, and greater distress; lower scores indicate low perceived personal and treatment control and less understanding of the illness (for score ranges, see Table 2 ). Participants completed the IPQ6R within 6 months post6diagnosis. 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Table 2 Measures were administered via the ePOCS system, which is accessible from any internet6 enabled device. Participants were not permitted to skip questions, but had the option to indicate they "prefer not to answer". There were no IPQ6R differences between participants included in these analyses and those who completed some portion of the IPQ6R but are not here included (all p≥0.126, except treatment control p=0.058). On average, participants completed the IPQ6R 3. As Table 2 shows, on average, participants did not tend to believe their cancer would last a long time and had strong beliefs that it was treatable, although also had relatively strong The QLACS scores show that many participants were experiencing relatively few problems and concerns, although for each domain a small proportion of participants obtained scores indicating very low HRQoL. All IPQ6R dimensions and QLACS domains had acceptable internal reliability (α≥.70).
Analysis

Sociodemographic and clinical factors predicting 15 month HRQoL
The results of the regression analyses are summarised in Tables 3 and 4 were not predictive of any of the QLACS domains. Age was a significant predictor of three domains, such that older participants reported higher HRQoL. SES was associated with five domains, such that one or more quintiles reported higher HRQoL than the most deprived quintile. Diagnosis was also a predictor, such that breast patients reported lower HRQoL than colorectal (four domains) and prostate (two domains) patients.
Illness perceptions predicting 15 month HRQoL
As shown in Tables 3 and 4 
Discussion
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